Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...

Pfizer (PFE) shares have shown some movement this week, drawing attention for investors evaluating the company’s current ...

To get a sense of who is truly in control of Pfizer Inc. (NYSE:PFE), it is important to understand the ownership structure of ...

Fintel reports that on December 2, 2025, Citigroup reiterated coverage of Pfizer (NYSE:PFE) with a Neutral recommendation.

Pfizer Inc. (NYSE:PFE) is one of the best low volatility large cap stocks to invest in. On November 24, Guggenheim lifted the ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer remains a great buy for dividend-oriented investors, with the rich forward yields and the upcoming payout hike well covered by the cash flows. This is significantly aided by the discounted ...

Pfizer PFE stock has been trading above its 50-day moving average since early November, indicating a potential short-term bullish trend. The 50-day SMA is a key indicator for traders and analysts, ...

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer was recently asked about. During the episode, a caller inquired if the ...

In the ever-evolving landscape of the biopharmaceutical industry, Pfizer Inc. (NYSE:PFE) has emerged as a noteworthy player, particularly for investors seeking stability. Recently, Guggenheim raised ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.